Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Rossignol Medical Center

Clinical trials sponsored by Rossignol Medical Center, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New antibody trial aims to ease core autism symptoms Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Completed 1

New antibody trial aims to ease core autism symptoms

Symptom relief Recruiting now

This Phase 2 study tests whether TB006, an antibody that targets a protein called Galectin-3, can improve core symptoms of autism in adults aged 18 to 35. Forty-five participants will be randomly assigned to receive either TB006 or a placebo for 14 weeks, with an open-label exten…

Phase 2 • Sponsor: Rossignol Medical Center • Aim: Symptom relief

Last updated Jun 27, 2026 12:07 UTC